Ipratropium Bromide
Ipratropium Bromide is a pharmaceutical drug with 21 clinical trials. Currently 1 active trials ongoing. Historical success rate of 94.1%.
Success Metrics
Based on 16 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
4
Mid Stage
12
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
94.1%
16 of 17 finished
5.9%
1 ended early
1
trials recruiting
21
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Effect of Ipratropium Bromide on EILO
Treating Respiratory Emergencies in Children Study
Defining and Treating Depression-related Asthma
Revefenacin in Acute Respiratory Insufficiency in COPD
Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)
Clinical Trials (21)
Effect of Ipratropium Bromide on EILO
Treating Respiratory Emergencies in Children Study
Defining and Treating Depression-related Asthma
Revefenacin in Acute Respiratory Insufficiency in COPD
Role of Parasympathetic Activity in Mild to Severe Asthma With Fixed Airway Obstruction (PARASMA Study)
Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes
Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease
Ipratropium Bromide Spray as Treatment for Sialorrhea in Children
Ipratropium Bromide in Peri-Operative COPD
Study of Budesonide as an Addition to Standard Therapy in Adult Asthmatics in the Emergency Room.
Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation
Ventilation-drive Coupling to Evaluate The Efficacy of Inhaled Bronchodilators in Patients With COPD
Study to Assess the Efficacy of Ipratropium Bromide Associated With High Dose Salbutamol by Repeated Nebulisation Versus Repeat Nebulisation of Salbutamol Alone, in Acute Asthmatic Attacks in Young Children
Actuation Indicator Trial in Patients With COPD
Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease
Budesonide Inhalation Suspension for Acute Asthma in Children
Effects of Bronchodilators in Mild Chronic Obstructive Pulmonary Disease (COPD)
Sensitivity of New Exercise Tests in Chronic Obstructive Pulmonary Disease (COPD)
Magnesium Sulfate Versus Ipratropuim Bromide in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Study to Assess the Effect of Salbutamol and Ipratropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 21